Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 1
2005 1
2006 2
2007 2
2008 1
2009 1
2010 4
2011 3
2012 1
2013 8
2014 1
2015 9
2016 7
2017 5
2018 12
2019 5
2020 11
2021 6
2022 8
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
The international WAO/EAACI guideline for the management of hereditary angioedema-The 2021 revision and update.
Maurer M, Magerl M, Betschel S, Aberer W, Ansotegui IJ, Aygören-Pürsün E, Banerji A, Bara NA, Boccon-Gibod I, Bork K, Bouillet L, Boysen HB, Brodszki N, Busse PJ, Bygum A, Caballero T, Cancian M, Castaldo A, Cohn DM, Csuka D, Farkas H, Gompels M, Gower R, Grumach AS, Guidos-Fogelbach G, Hide M, Kang HR, Kaplan AP, Katelaris C, Kiani-Alikhan S, Lei WT, Lockey R, Longhurst H, Lumry WR, MacGinnitie A, Malbran A, Martinez Saguer I, Matta JJ, Nast A, Nguyen D, Nieto-Martinez SA, Pawankar R, Peter J, Porebski G, Prior N, Reshef A, Riedl M, Ritchie B, Rafique Sheikh F, Smith WB, Spaeth PJ, Stobiecki M, Toubi E, Varga LA, Weller K, Zanichelli A, Zhi Y, Zuraw B, Craig T. Maurer M, et al. Among authors: zanichelli a. Allergy. 2022 Jul;77(7):1961-1990. doi: 10.1111/all.15214. Epub 2022 Feb 3. Allergy. 2022. PMID: 35006617
Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial.
Banerji A, Riedl MA, Bernstein JA, Cicardi M, Longhurst HJ, Zuraw BL, Busse PJ, Anderson J, Magerl M, Martinez-Saguer I, Davis-Lorton M, Zanichelli A, Li HH, Craig T, Jacobs J, Johnston DT, Shapiro R, Yang WH, Lumry WR, Manning ME, Schwartz LB, Shennak M, Soteres D, Zaragoza-Urdaz RH, Gierer S, Smith AM, Tachdjian R, Wedner HJ, Hebert J, Rehman SM, Staubach P, Schranz J, Baptista J, Nothaft W, Maurer M; HELP Investigators. Banerji A, et al. Among authors: zanichelli a. JAMA. 2018 Nov 27;320(20):2108-2121. doi: 10.1001/jama.2018.16773. JAMA. 2018. PMID: 30480729 Free PMC article. Clinical Trial.
Long-term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study.
Banerji A, Bernstein JA, Johnston DT, Lumry WR, Magerl M, Maurer M, Martinez-Saguer I, Zanichelli A, Hao J, Inhaber N, Yu M, Riedl MA; HELP OLE Investigators. Banerji A, et al. Among authors: zanichelli a. Allergy. 2022 Mar;77(3):979-990. doi: 10.1111/all.15011. Epub 2021 Aug 13. Allergy. 2022. PMID: 34287942 Free PMC article. Clinical Trial.
The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update.
Maurer M, Magerl M, Betschel S, Aberer W, Ansotegui IJ, Aygören-Pürsün E, Banerji A, Bara NA, Boccon-Gibod I, Bork K, Bouillet L, Boysen HB, Brodszki N, Busse PJ, Bygum A, Caballero T, Cancian M, Castaldo AJ, Cohn DM, Csuka D, Farkas H, Gompels M, Gower R, Grumach AS, Guidos-Fogelbach G, Hide M, Kang HR, Kaplan AP, Katelaris CH, Kiani-Alikhan S, Lei WT, Lockey RF, Longhurst H, Lumry W, MacGinnitie A, Malbran A, Martinez Saguer I, Matta Campos JJ, Nast A, Nguyen D, Nieto-Martinez SA, Pawankar R, Peter J, Porebski G, Prior N, Reshef A, Riedl M, Ritchie B, Sheikh FR, Smith WB, Spaeth PJ, Stobiecki M, Toubi E, Varga LA, Weller K, Zanichelli A, Zhi Y, Zuraw B, Craig T. Maurer M, et al. Among authors: zanichelli a. World Allergy Organ J. 2022 Apr 7;15(3):100627. doi: 10.1016/j.waojou.2022.100627. eCollection 2022 Mar. World Allergy Organ J. 2022. PMID: 35497649 Free PMC article.
Diagnosing angioedema.
Cicardi M, Zanichelli A. Cicardi M, et al. Among authors: zanichelli a. Immunol Allergy Clin North Am. 2013 Nov;33(4):449-56. doi: 10.1016/j.iac.2013.07.001. Epub 2013 Aug 24. Immunol Allergy Clin North Am. 2013. PMID: 24176210 Review.
Acquired angioedema.
Cicardi M, Zanichelli A. Cicardi M, et al. Among authors: zanichelli a. Allergy Asthma Clin Immunol. 2010 Jul 28;6(1):14. doi: 10.1186/1710-1492-6-14. Allergy Asthma Clin Immunol. 2010. PMID: 20667117 Free PMC article.
Lanadelumab for the prevention of attacks in hereditary angioedema.
Valerieva A, Senter R, Wu MA, Zanichelli A, Cicardi M. Valerieva A, et al. Among authors: zanichelli a. Expert Rev Clin Immunol. 2019 Dec;15(12):1239-1248. doi: 10.1080/1744666X.2020.1693261. Epub 2019 Nov 19. Expert Rev Clin Immunol. 2019. PMID: 31721602 Review.
Recurrent Retroperitoneal Angioedema.
Wu MA, Ippolito S, Zanichelli A, Perego F, Cicardi M. Wu MA, et al. Among authors: zanichelli a. J Allergy Clin Immunol Pract. 2018 Jul-Aug;6(4):1384-1385. doi: 10.1016/j.jaip.2018.04.019. Epub 2018 May 3. J Allergy Clin Immunol Pract. 2018. PMID: 29729442 No abstract available.
Angioedema Phenotypes: Disease Expression and Classification.
Wu MA, Perego F, Zanichelli A, Cicardi M. Wu MA, et al. Among authors: zanichelli a. Clin Rev Allergy Immunol. 2016 Oct;51(2):162-9. doi: 10.1007/s12016-016-8541-z. Clin Rev Allergy Immunol. 2016. PMID: 27113957 Review.
Current and emerging biologics for the treatment of hereditary angioedema.
Perego F, Wu MA, Valerieva A, Caccia S, Suffritti C, Zanichelli A, Bergamaschini L, Cicardi M. Perego F, et al. Among authors: zanichelli a. Expert Opin Biol Ther. 2019 Jun;19(6):517-526. doi: 10.1080/14712598.2019.1595581. Epub 2019 Mar 26. Expert Opin Biol Ther. 2019. PMID: 30912460 Free article. Review.
86 results